돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 1161164생성일: 2026년 10월 24일

Lithium Carbonate → 1-{2-Hydroxy-4-[3-(3-iodo-benzyl)-[1,2,4]oxadiazol-5-ylmethoxy]-3-methyl-phenyl}-ethanone

https://huagongshe.com/ko/reaction/1161164

반응식

참여 물질

역할이름HCID투입량
반응물Lithium CarbonateHCID 11125—
반응물3-(3-Amino-1,2,4-oxadiazol-5-yl)-1-azabicyclo(2.2.1)heptaneHCID 163938—
반응물1-(2,4-Dihydroxy-3-methylphenyl)ethan-1-oneHCID 592139—
반응물5-Chloromethyl-3-(3-iodo-benzyl)-[1,2,4]oxadiazoleHCID 57438412—
용매WaterHCID 962—
용매DimethylformamideHCID 6228—
생성물1-{2-Hydroxy-4-[3-(3-iodo-benzyl)-[1,2,4]oxadiazol-5-ylmethoxy]-3-methyl-phenyl}-ethanoneHCID 6669962153.8%

반응 조건

온도60 °C

반응 단계

Add lithium carbonate (49 mg, 0.66 mmol) and 5-chloromethyl-3-(3-iodo-benzyl)-[1,2,4]oxadiazole (200 mg, 0.60 mmol) to a solution of 1-(2,4-dihydroxy-3-methyl-phenyl)-ethanone (110 mg, 0.66 mmol) in anhydrous dimethylformamide (20 mL) 4]oxadiazole (200 mg, 0.60 mmol). Heat the reaction mixture at 60° C. overnight. Cool the reaction mixture to RT, pour into H2O, and extract with diethyl ether (3×). Combine the organic layers, wash with brine, dry over sodium sulfate, and concentrate to provide the title compound (150 mg). LC-MS (m/e): 463 (M−1).

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US07816523B2
출처 데이터셋uspto-grants-2010_10
ORD IDord-c814fed80f374eaa9ec6e4f4ef97c3c8
출처 메모uspto-grants-2010_10